Prisma Health.
Clin J Oncol Nurs. 2021 Feb 1;25(1):28-32. doi: 10.1188/21.CJON.28-32.
Convalescent plasma has emerged as a treatment that merits consideration for COVID-19-positive patients requiring hospitalization. With millions of cases of COVID-19 being reported worldwide, nurses across specialties are caring for infected patients and are often the primary patient educators about convalescent plasma treatment. Keeping abreast of current clinical guidelines and evidence-based practice allows nurses to identify patients who should be considered for treatment, understand the administration guidelines, and be aware of the toxicity profile to provide safe and high-quality care to patients. The purpose of this article is to provide information on convalescent plasma as a treatment for COVID-19.
恢复期血浆作为一种治疗方法,已经引起了人们的关注,值得考虑用于需要住院治疗的 COVID-19 阳性患者。随着全球数百万例 COVID-19 病例的报告,各专业的护士都在照顾感染患者,并且经常是关于恢复期血浆治疗的主要患者教育者。了解当前的临床指南和循证实践,使护士能够识别应考虑进行治疗的患者,了解管理指南,并了解毒性特征,从而为患者提供安全和高质量的护理。本文的目的是提供关于恢复期血浆作为 COVID-19 治疗方法的信息。